EUVIMEDEUVIMED entdecken
Crossref

A Novel Aldehyde Scavenging Modification Boosted Pericardium Valve Materials against Calcification

Fei Kong, Jingjing Zhang, Yang Yang, Yunyang Zhang, Jian Ge, Jingwu Song, Changyu Shao, Haoran Li, Yunjiu Ren, Xianghui Kong, Chengyao Ni, Xiangdong Kong und 1 weitere

Advanced Healthcare Materials · 2025-07 · 14 (18)

DOI: 10.1002/adhm.202500856 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 26.05.2025. Verfasst von Fei Kong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Smart Biomedical Materials, School of Materials Science & Engineering, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China. Hauptthemen laut MEDLINE: Pericardium, Calcinosis, Heart Valve Prosthesis, Bioprosthesis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Fundamental Research Funds of Zhejiang Sci-Tech University, Interdisciplinary Construction Funding of Biomedical Materials in ZSTU, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calcific aortic valve disease is an inexorably degenerative pathology and a common cause of morbidity and mortality in heart disease. Clinically, it has no effective medical therapy but can be managed with artificial heart valve replacement, particularly using bioprosthetic heart valves (BHV), entailing high biocompatibility. Current BHV mainly derives from glutaraldehyde (GA) cross‐linked pericardium, however, residual aldehyde groups may inevitably remain during cross‐link, potentially binding with calcium and inducing in situ calcification after implantation, thus leading to valve re‐failure and posing a significant clinical challenge. Inspired by the high reducibility and clinical potential of sodium thiosulfate (STS), herein, STS as a novel modification post GA cross‐linking to eliminate residual aldehyde in pericardium is presented. Notably, in vitro and in vivo studies demonstrated high ability against calcification in STS‐modified porcine pericardium (SPP) with over 75% decrease of calcific density compared to GA alone cross‐linked pericardium (GPP). More importantly, SPP can reduce macrophages and T cell inflation, as well as their associated proinflammation cytokines, building an immune‐privileged microenvironment with a suppressed inflammation response. More generally, given the great potential of STS in treating vascular calcification clinically, these achievements further offer a new generation of BHV materials with boosted anti‐calcification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PericardiumCalcinosisHeart Valve ProsthesisBioprosthesisAldehydesAortic ValveAnimalsSwineMiceGlutaralThiosulfatesHumansMacrophagesCross-Linking Reagents

Stichwörter der Autor:innen

anti‐calcificationbiocompatibilitybioprosthetic heart valveglutaraldehyde cross‐linked

Substanzen

AldehydesGlutaralsodium thiosulfateThiosulfatesCross-Linking Reagents

Autor:innen und Institutionen

  • Institute for Smart Biomedical Materials, School of Materials Science & Engineering, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China.
  • Zhejiang-Mauritius Joint Research Center for Biomaterials and Tissue Engineering, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China.
  • College of Life Sciences, China Jiliang University, Hangzhou, Zhejiang, 310018, China.
  • Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310016, China.
  • Department of Cardiothoracic Medicine, The Central Hospital of Linyi City, Linyi, Shandong, 276400, China.
  • Department of Cardiothoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China.

ORCID-Profile: Ruibo Zhao

Förderung

  • Fundamental Research Funds of Zhejiang Sci-Tech University
  • Interdisciplinary Construction Funding of Biomedical Materials in ZSTU
  • Natural Science Foundation of Zhejiang Province
  • Key Research and Development Program of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Kong, F., Zhang, J., Yang, Y., Zhang, Y., Ge, J., Song, J., Shao, C., Li, H., Ren, Y., Kong, X., Ni, C., Kong, X., & Zhao, R. (2025). A Novel Aldehyde Scavenging Modification Boosted Pericardium Valve Materials against Calcification. Advanced Healthcare Materials, 14(18). https://doi.org/10.1002/adhm.202500856

Vancouver

Kong F, Zhang J, Yang Y, Zhang Y, Ge J, Song J, et al. A Novel Aldehyde Scavenging Modification Boosted Pericardium Valve Materials against Calcification. Advanced Healthcare Materials. 2025;14(18). doi:10.1002/adhm.202500856

BibTeX
@article{Kong2025,
  author = {Kong, Fei and Zhang, Jingjing and Yang, Yang and Zhang, Yunyang and Ge, Jian and Song, Jingwu and Shao, Changyu and Li, Haoran and Ren, Yunjiu and Kong, Xianghui and Ni, Chengyao and Kong, Xiangdong and Zhao, Ruibo},
  title = {A Novel Aldehyde Scavenging Modification Boosted Pericardium Valve Materials against Calcification},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {18},
  doi = {10.1002/adhm.202500856}
}
Kostenlos starten →